Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Holders of 5% or more of PRVB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Provention Bio, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Provention Bio, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Provention Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 21, 2023 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | – | – | SEC |
| Feb 14, 2023 | Sessa Capital (Master), L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Adage Capital Partners GP, L.L.C. | 13G/AOld format | – | – | – | SEC |
| Aug 26, 2022 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
| Jul 11, 2022 | Sessa Capital (Master), L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Sessa Capital (Master), L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:29 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jun 7, 2021 | Venrock Healthcare Capital Partners II, L.P. | 13GOld format | – | New | – | SEC |
| Apr 19, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Appel Peter A | 13G/AOld format | – | – | – | SEC |
| Feb 5, 20214:31 PM ET | Amgen Inc | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20213:13 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Provention Bio, Inc. shares.
No Form 144 notices for Provention Bio, Inc. are on file.